Announcement on Change of Senior Management Member
Filed with SSE · · 3 pages · Chinese
Summary by 6ix AI
The company confirmed that the resignation would not affect its operations and expressed gratitude for the contributions made by the departing executive.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
KPC Pharmaceuticals, Inc. on 6ix
Earlier from KPC Pharmaceuticals
- Indicative Announcement on the Publication of the 2025 Performance Announcement by CR Pharmaceutical Group Co., Ltd., an Indirectly Controlling Shareholder of the Controlling Shareholder
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Change of Partial Directors and Senior Management Members
- Preliminary Earnings Estimate for 2025
- Announcement on Resignation of Director
Later from KPC Pharmaceuticals
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Obtaining Drug Registration Certificate
- Report for Q1 2026
- Indicative Announcement on Controlling Shareholder's Equity Change Reaching 1% Scale
- Announcement on Remuneration Plan for Directors and Senior Management Members in 2026
Follow KPC Pharmaceuticals into a list and get an email when it puts out news.
Follow KPC Pharmaceuticals